Wells Fargo’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $568K | Sell |
|
|||||
|
2023
Q3 | $6.47M | Buy |
|
|||||
|
2023
Q2 | $3.93M | Buy |
|
|||||
|
2023
Q1 | $3.79M | Buy |
|
|||||
|
2022
Q4 | $3.34M | Buy |
|
|||||
|
2022
Q3 | $4.59M | Sell |
|
|||||
|
2022
Q2 | $4.72M | Sell |
|
|||||
|
2022
Q1 | $7.52M | Buy |
|
|||||
|
2021
Q4 | $9.23M | Sell |
|
|||||
|
2021
Q3 | $50.6M | Sell |
|
|||||
|
2021
Q2 | $52.6M | Buy |
|
|||||
|
2021
Q1 | $55.5M | Buy |
|
|||||
|
2020
Q4 | $66M | Buy |
|
|||||
|
2020
Q3 | $35M | Buy |
|
|||||
|
2020
Q2 | $6.7M | Buy |
|
|||||
|
2020
Q1 | $3.48M | Buy |
|
|||||
|
2019
Q4 | $5.19M | Sell |
|
|||||
|
2019
Q3 | $20.4M | Sell |
|
|||||
|
2019
Q2 | $27.6M | Sell |
|
|||||
|
2019
Q1 | $25.3M | Sell |
|
|||||
|
2018
Q4 | $15M | Buy |
|
|||||
|
2018
Q3 | $12.4M | Buy |
|
|||||
|
2018
Q2 | $515K | Buy |
|
|||||
|
2018
Q1 | $71K | Buy |
|
|||||
|
2017
Q4 | $13K | Hold |
|
|||||
|
2017
Q3 | $8K | Buy |
|
|||||
|
2017
Q2 | – | Sell |
|
|||||
|
2017
Q1 | $74K | Buy |
|
|||||
|
2016
Q4 | $14K | Sell |
|
|||||
|
2016
Q3 | $22K | Buy |
|
|||||
|
2016
Q2 | $16K | Sell |
|
|||||
|
2016
Q1 | $92K | Buy |
|
|||||
|
2015
Q4 | $119K | Buy |
|
|||||
|
2015
Q3 | $126K | Sell |
|
|||||
|
2015
Q2 | $129K | Buy |
|
|||||
|
2015
Q1 | $69K | Buy |
|
|||||
|
2014
Q4 | $19K | Buy |
|
|||||
|
2014
Q3 | $18K | Sell |
|
|||||
|
2014
Q2 | $24K | Sell |
|
|||||
|
2014
Q1 | $68K | Buy |
|
|||||
|
2013
Q4 | $11K | Hold |
|
|||||
|
2013
Q3 | $10K | Buy |
|